Target intelligence / Profile preview

Ovarian support cell-oocyte interaction (OSC-oocyte interaction)

Target
OSC-oocyte interaction
Molecular classification
Other
01

Overview

Ovarian support cell-oocyte interaction refers to the complex, bidirectional communication between the developing oocyte and its surrounding somatic support cells, primarily granulosa and cumulus cells. This interaction is essential for the maturation of the oocyte, regulating both nuclear and cytoplasmic development through gap junction-mediated metabolic exchange and paracrine signaling pathways, such as the Kit ligand/c-Kit and GDF9/BMP15 axes [1, 3]. Somatic cells provide the oocyte with essential nutrients and regulatory molecules like cAMP and cGMP, while the oocyte secretes factors that promote granulosa cell proliferation and function [3, 5]. Disruptions in this communication are linked to clinical conditions like primary ovarian insufficiency (POI), polycystic ovary syndrome (PCOS), and age-related fertility decline [2, 5]. In the therapeutic landscape, this interaction is the focus of novel in vitro maturation (IVM) platforms, such as Gameto's Fertilo, which uses iPSC-derived ovarian support cells (OSCs) to recreate the natural follicular environment in a laboratory setting [1, 4]. These technologies aim to improve fertility outcomes by enhancing oocyte competence for patients who do not respond well to traditional hormonal stimulation or who wish to avoid intensive gonadotropin protocols [2, 3].

Other names
Oocyte-granulosa cell communicationBidirectional follicular signalingOocyte-somatic cell crosstalkGerm cell-somatic cell interactionFollicular microenvironment
02

Mechanism of action

Restoration of bidirectional signaling and metabolic support through paracrine factors and gap junctions to enable oocyte cytoplasmic and nuclear maturation.

03

Biological functions

Oocyte maturationFolliculogenesisMeiotic regulationSteroidogenesisNutrient transportCell-cell communication
04

Disease associations

Female infertilityPrimary Ovarian InsufficiencyPolycystic Ovary Syndrome (PCOS)Ovarian agingPoor ovarian response
05

Safety considerations

Aneuploidy riskEpigenetic stability of the embryoLong-term developmental safety of offspringOff-target maturation of low-quality oocytes
06

Interacting drugs

Fertilo (OSC-IVM platform)

4 more in the full profile.

07

Biomarkers

Anti-Müllerian Hormone (AMH)Growth differentiation factor 9 (GDF9)Bone morphogenetic protein 15 (BMP15)Metaphase II (MII) oocyte rateEstradiol

Beyond the preview

Go deeper on Ovarian support cell-oocyte interaction (OSC-oocyte interaction).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovarian support cell-oocyte interaction (OSC-oocyte interaction).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call